Hypogammaglobulinemia and severe infection risk in patients with autoimmune diseases during rituximab treatment
Authors:
- Sema Kaymaz TahraSTSema Kaymaz Tahra
- Fatma Alibaz-ÖnerFAFatma Alibaz-Öner
- Taylan KaplanTKTaylan Kaplan
- Yasemin YalçınkayaYYYasemin Yalçınkaya
- Nevsun İnançNINevsun İnanç
- Mehmet Pamir AtagündüzMAMehmet Pamir Atagündüz
- Dilek Barutcu AtaşDADilek Barutcu Ataş
- Ebru AşıcıoğluEAEbru Aşıcıoğlu
- Zübeyde Serhan TuğlularZTZübeyde Serhan Tuğlular
- Haner DireskeneliHDHaner Direskeneli
- 27 November 2023
- journal article
- research article
- Published by Galenos Yayinevi in Ulusal Romatoloji Dergisi
- Vol. 15 (3) , 154-161
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 PatientsArthritis & Rheumatology, 2019
- Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and HypogammaglobulinemiaJAMA Network Open, 2018
- Effect of Continuous B Cell Depletion With Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody–Associated VasculitisArthritis & Rheumatology, 2016
- Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long‐Term Effects on Serum ImmunoglobulinsArthritis Care & Research, 2016
- Use of Rituximab in Systemic Lupus Erythematosus: A Single Center Experience Over 14 YearsArthritis Care & Research, 2016
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registryArthritis & Rheumatism, 2010
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trialArthritis & Rheumatism, 2009
- The effects of rituximab on immunocompetency in patients with autoimmune diseaseArthritis & Rheumatism, 2007
- Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open‐label extension analysisArthritis & Rheumatism, 2007
- The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trialArthritis & Rheumatism, 2006